(A) Representative immunofluorescence images and quantification of Tamoxifen induced Sox9-CreER::Ai14 mice indicating efficient labeling of bulge epithelial cells but not McSCs. DCT is a melanocyte …
(A) Representative tail skin immunofluorescence images of Sox9 in WT and Sox9-CreER::RBP-J cKO HFs at P18 anagen. Note the expression pattern of Sox9 is similar in cKO compared to WT bulge. (B) …
(A) Schematic diagram of CRISPR/Cas9-mediated knockin of CreER in the 3’ UTR of Krt6a locus. sgRNA targets downstream of Krt6a stop codon. Two pair of indicated primers spanning the junctions of …
(A) Representative fluorescent image and quantification of Krt6-CreER labeling pattern in telogen HFs. (B) FACS profile and quantification of HFSC labeling efficiency using Krt6-CreER::Ai6 mice. …
(A) Representative immunofluorescence images of RBP-J demonstrate broad expression pattern in HF epithelial cells at all stages of hair cycle from morphogenesis to adult. Krt14 is a basal epithelial …
(A) Schematic diagram of P13 anagen HF used for FACS analysis. HFSCs marked in red reside in upper HF just beneath the sebaceous gland. Matrix cells containing terminally differentiated cells marked …
(A) Representative non-specific lipid marker Oil Red O staining in the WT and Krt6-CreER::RBP-J cKO HFs at telogen. Follicles are counter-stained by hematoxylin. Note the normal and restricted red …
(A) ATAC-seq signal comparison between FACS isolated HFSCs from WT and Krt6-CreER::RBP-J cKO HFs at D2 after wax. Each dot represents an ATAC-seq peak. Regions with more accessibility in cKO than in …
(A) Schematic diagram of retinoic acid synthesis inhibitor treatment experiment. Tamoxifen was injected on P50-52 at telogen to induce ablation of RBP-J in Krt6-CreER::RBP-J mice, then CPL cells …
(A) FACS profile of HG cells and qPCR validation of marker genes. Sca1 was used to exclude epidermis. CD34 was used to exclude HFSC and HG cells were gated as Sca1-, CD34-, Pcadhigh. (B) FACS …
(A) Schematic diagram, FACS profiles and quantification of c-Kit+ McSCs in telogen HFs from WT and Krt6-CreER::RBP-J cKO mice after indicated treatments. Tamoxifen was injected on P50-52 at telogen …
(A) Percentage of c-Kit+ cells quantified by FACS under indicated treatments in WT and Sox9-CreER::RBP-J skin. (B) Schematic diagram, FACS profiles and quantification of c-Kithigh/c-Kit+ McSCs in …
(A) Representative immunofluorescence images and quantification of pERK+ McSCs in WT and Krt6-CreER::RBP-J cKO HFs. (B) Representative dorsal skin Masson-Fontana staining images and quantification …
Genes Up-regulated in RBP-J cKO versus WT dorsal HFSCs.
RNA-seq analysis of WT and cKO HFSCs isolated from Krt6-CreER::RBP-J mice at D2 after wax to profile their transcriptome difference. Since RBP-J serves as a repressor in HFSCs, genes regulated >1.5 fold (p<0.05) in cKO compared to WT HFSCs were mainly focused.
Primer sequences used.